Multiplicity: An organizing principle for cancers and somatic mutations

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Frey, Lewis J ^a,b   Piccolo, Stephen R ^a,b   Edgerton, Mary E ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; CLUSTER ANALYSIS; CORRELATION COEFFICIENT; GENE CLUSTER; GENE MUTATION; GENETIC DATABASE; GENETIC LINKAGE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MUTATIONAL ANALYSIS; ONCOGENE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SOMATIC MUTATION; ALGORITHM; GENETICS; MUTATION; NEOPLASM;

ALGORITHMS; CLUSTER ANALYSIS; HUMANS; MUTATION; NEOPLASMS;

EID: 79959662801     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-52     Document Type: Article

References (36)

1. The cancer genome challenge. H Ledford, Nature 2010 464 972 974 10.1038/464972a 20393534
2. The genomic landscapes of human breast and colorectal cancers. LD Wood, DW Parsons, S Jones, J Lin, T Sjöblom, RJ Leary, D Shen, SM Boca, T Barber, J Ptak, N Silliman, S Szabo, Z Dezso, V Ustyanksky, T Nikolskaya, Y Nikolsky, R Karchin, PA Wilson, JS Kaminker, Z Zhang, R Croshaw, J Willis, D Dawson, M Shipitsin, JKV Willson, S Sukumar, K Polyak, BH Park, CL Pethiyagoda, PV Krishna Pant, et al. Science(New York, N.Y) 2007 318 1108 13 (Pubitemid 350134889)
3. Cancer genes and the pathways they control. B Vogelstein, KW Kinzler, Nature Medicine 2004 10 789 99 10.1038/nm1087 15286780 (Pubitemid 39070849)
4. The Pezcoller lecture: cancer cell cycles revisited. CJ Sherr, Cancer Research 2000 60 3689 95 10919634 (Pubitemid 32204552)
5. Cyclin D-dependent kinases, INK4 inhibitors and cancer. S Ortega, M Malumbres, M Barbacid, Biochimica et Biophysica Acta 2002 1602 73 87 11960696 (Pubitemid 34311901)
6. From genomics to chemical genomics: new developments in KEGG. M Kanehisa, S Goto, M Hattori, KF Aoki-Kinoshita, M Itoh, S Kawashima, T Katayama, M Araki, M Hirakawa, Nucleic Acids Research 2006 34 354 D357 10.1093/nar/gkj102 16381885
7. Lessons from hereditary colorectal cancer. KW Kinzler, B Vogelstein, Cell 1996 87 159 70 10.1016/S0092-8674(00)81333-1 8861899 (Pubitemid 26358996)
8. Patterns of somatic mutation in human cancer genomes. C Greenman, P Stephens, R Smith, GL Dalgliesh, C Hunter, G Bignell, H Davies, J Teague, A Butler, C Stevens, S Edkins, S O'Meara, I Vastrik, EE Schmidt, T Avis, S Barthorpe, G Bhamra, G Buck, B Choudhury, J Clements, J Cole, E Dicks, S Forbes, K Gray, K Halliday, R Harrison, K Hills, J Hinton, A Jenkinson, D Jones, et al. Nature 2007 446 153 158 10.1038/nature05610 17344846 (Pubitemid 46398669)
9. A genetic model for colorectal tumorigenesis. ER Fearon, B Vogelstein, Cell 1990 61 759 767 10.1016/0092-8674(90)90186-I 2188735 (Pubitemid 20185636)
10. WD Nooy, A Mrvar, V Bataelj, Exploratory Social Network Analysis with Pajek New York: Cambridge University Press 2005
11. Wellcome Trust Sanger Institute, Germline mutated cancer genes Hinxton, Cambridge 2010
12. UKPMC Funders Group: a census of human cancer genes. PA Futreal, L Coin, M Marshall, T Down, T Hubbard, R Wooster, N Rahman, MR Stratton, Cancer 2009 4 177 183 (Pubitemid 38337497)
13. COSMIC 2005. S Forbes, J Clements, E Dawson, S Bamford, T Webb, A Dogan, A Flanagan, J Teague, R Wooster, PA Futreal, MR Stratton, British Journal of Cancer 2006 94 318 322 10.1038/sj.bjc.6602928 16421597 (Pubitemid 43151554)
14. Catalogue of Somatic Mutations in Cancer. http://www.sanger.ac.uk/ genetics/CGP/cosmic/
15. On closed world data bases. R Reiter, San Francisco: Morgan Kaufmann Publishers Inc 1987 300 310
16. Genetic predisposition to colorectal cancer. A de la Chapelle, Nature reviews Cancer 2004 4 769 80 10.1038/nrc1453 15510158 (Pubitemid 39331149)
17. Hierarchical grouping to optimize an objective function. JH Ward, American Statistical Association 1963 58 236 244 10.2307/2282967
18. An algorithm for drawing general undirected graphs. T Kamada, S Kawai, Information Processing Letters 1989 31 7 15 10.1016/0020-0190(89)90102-6
19. Somatic mutation signatures of cancer. SR Piccolo, LJ Frey, AMIA Annu Symp Proc Washington D.C. Published online 2008 202 206 18999255
20. International network of cancer genome projects. TJ Hudson, W Anderson, A Aretz, AD Barker, C Bell, RR Bernabe, MK Bhan, F Calvo, I Eerola, DS Gerhard, A Guttmacher, M Guyer, FM Hemsley, JL Jennings, D Kerr, P Klatt, P Kolar, J Kusuda, DP Lane, F Laplace, Y Lu, G Nettekoven, B Ozenberger, J Peterson, TS Rao, J Remacle, AJ Schafer, T Shibata, MR Stratton, JG Vockley, et al. Nature 2010 464 993 998 10.1038/nature08987 20393554
21. Molecular interactions in the Vogelstein model of colorectal carcinoma. JW Arends, J Pathol 2000 190 4 412 416 10.1002/(SICI)1096-9896(200003)190: 4<412::AID-PATH533>3.0.CO;2-P 10699988 (Pubitemid 30163579)
22. Linkage of early-onset familial breast to chromosome 17q21 cancer. JM Hall, MK Lee, B Newman, JE Morrow, LA Anderson, B Huey, MC King, Advancement of Science 1990 250 1684 1689 (Pubitemid 120031871)
23. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. R Wooster, S Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, K Nguyen, S Seal, T Tran, D Averill, P Fields, G Marshall, S Narod, GM Lenoir, H Lynch, J Feunteun, P Devilee, CJ Cornelisse, FH Menko, PA Daly, W Ormiston, R McManus, C Pye, CM Lewis, LA Cannon-Albright, J Peto, BAJ Ponder, MH Skolnick, DF Easton, DE Goldgar, R Michael, Science 1994 265 2088 2090 10.1126/science.8091231 8091231 (Pubitemid 24325690)
24. Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases. Y Sun, Y Ren, Z Fang, C Li, R Fang, B Gao, X Han, W Tian, W Pao, H Chen, H Ji, Journal of Clinical Oncology 2010 28 4616 4620 10.1200/JCO.2010.29.6038 20855837
25. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. M-d-M Inda, R Bonavia, A Mukasa, Y Narita, DWY Sah, S Vandenberg, C Brennan, TG Johns, R Bachoo, P Hadwiger, P Tan, RA DePinho, W Cavenee, F Furnari, Genes Dev 2010 24 16 1731 1745 10.1101/gad.1890510 20713517
26. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma. P Topcu-Yilmaz, H Kiratli, A Saglam, F Söylemezoglu, G Hascelik, Melanoma Res 2010 20 126 132 10.1097/CMR. 0b013e328335a916 20061986
27. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. Y Liang, AW Bollen, KD Aldape, N Gupta, BMC Cancer 2006 6 97 10.1186/1471-2407-6-97 16623952 (Pubitemid 43885027)
28. Molecular diagnostics of gliomas: the clinical perspective. G Tabatabai, R Stupp, MJ van den Bent, ME Hegi, JC Tonn, W Wick, M Weller, Acta neuropathologica 2010 120 585 92 10.1007/s00401-010-0750-6 20862485
29. Potential of molecular targeted therapy of HER-2 and Cox-2 for invasive transitional cell carcinoma of the urinary bladder. K Naruse, Y Yamada, K Nakamura, S Aoki, T Taki, K Zennami, R Katsuda, M Watanabe, G Nishikawa, Y Itoh, K Mitsui, H Hibi, N Honda, Oncology reports 2010 23 1577 1583 20428812
30. Analysis and computational dissection of molecular signature multiplicity. A Statnikov, CF Aliferis, PLoS Computational Biology 2010 6 1000790 10.1371/journal.pcbi.1000790 20502670
31. Combinatorial patterns of somatic gene mutations in cancer. C-H Yeang, F McCormick, A Levine, FASEB J 2008 22 2605 2622 10.1096/fj.08-108985 18434431
32. SB Edge, DR Byrd, CC Compton, AG Fritz, FL Greene, A Trotti, AJCC Cancer Staging Manual New York: Springer 2009
33. Genomic landscapes of cancers: prospects for targeted therapies. FE Bleeker, A Bardelli, Pharmacogenomics 2007 8 1629 1633 10.2217/14622416.8.12. 1629 18085994
34. A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer. K Berns, HM Horlings, BT Hennessy, M Madiredjo, EM Hijmans, K Beelen, SC Linn, AM Gonzalez-Angulo, K Stemke-Hale, M Hauptmann, RL Beijersbergen, GB Mills, MJ van de Vijver, R Bernards, Cancer Cell 2007 12 395 402 10.1016/j.ccr.2007.08.030 17936563 (Pubitemid 47539306)
35. Status of PI3K inhibition and biomarker development in cancer therapeutics. B Markman, F Atzori, J Pérez-García, J Tabernero, J Baselga, Annals of Oncology ESMO 2010 21 683 691 10.1093/annonc/mdp347
36. Mapping the cancer genome. FS Collins, AD Barker, Scientific American 2007 296 50 57 17348159 (Pubitemid 46445886)